Lifecore Biomedical, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LDE.F | COLINZ.BO | 0950.HK | 1061.HK | AQST | SFZN.SW | |
|---|---|---|---|---|---|---|
| Market cap | 210.38M | 173.79M | 638.89M | 1.15B | 477.61M | 3.25B |
| P/E (TTM) | — | 6.2 | 5.4 | 4.4 | — | 19.0 |
| Forward P/E | 39.6 | — | 7.8 | 7.6 | -6.7 | 15.8 |
| Price/book | -3.2 | 1.7 | 0.3 | 0.5 | -6.7 | 3.3 |
| Dividend yield | — | — | 6.51% | 6.03% | — | 0.53% |
| 1-year change | −2.61% | +73.32% | −41.58% | −54.36% | −38.01% | +0.20% |
| Today | −0.89% | −0.01% | +0.93% | +2.76% | −2.06% | −0.93% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All LDE.F news ›Lifecore Biomedical 2026: Revenue $25.32M, Net income ($40.08M), EPS ($1.08) — 10-Q Summary
TradingView Lifecore Biomedical 2026: Revenue $25.32M, Net income ($40.08M), EPS ($1.08) — 10-Q Summary Lifecore Biomedical reported revenue of $25.32 million for the quarter, down 18.6% from the prior-year
Lifecore Biomedical (NASDAQ:LFCR) & Bausch Health Cos (NYSE:BHC) Head-To-Head Survey
Posted by Kim Johansen on Nov 4th, 2026 Bausch Health Cos (NYSE:BHC – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
November 04, 2026 07:05 ET | Source: Lifecore Biomedical, Inc. Lifecore Biomedical, Inc. -- Multiple New Business Wins Continue to Strengthen Growing Pipeline -- CHASKA, Minn., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc.…
Lifecore Biomedical (LFCR) Expected to Post Quarterly Earnings on Tuesday
Posted by Kim Johansen on Oct 27th, 2026 Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) is anticipated to issue its Q3 2026 resultson Tuesday, November 3rd. Analysts expect the company to post earnings of ($0.2975) per share and…
Head-To-Head Contrast: Lifecore Biomedical (NASDAQ:LFCR) vs. Astrazeneca (NYSE:AZN)
Posted by Kim Johansen on Oct 23rd, 2026 Astrazeneca (NYSE:AZN – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses…
Lifecore Biomedical (LFCR) was downgraded to a Hold Rating at William Blair
Lifecore Biomedical received a Hold rating and price target from William Blair analyst Jared Haase on October 3. According to TipRanks, Haase is a 4-star analyst with an average return of 17.2% and a 73.81% success rate. Haase covers the…
Lifecore Biomedical to Participate at Upcoming Industry Conferences - October 7, 2026
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…
More from 1 other outlet
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)
BALA CYNWYD, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc…
Lifecore Biomedical trading resumes
09:55 EDT Lifecore (LFCR) Biomedical trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fina... Lifecore Biomedical trading resumes 09:55 EDT Lifecore (LFCR) Biomedical trading resumes…
Lifecore Biomedical (NASDAQ:LFCR) vs. Evolus (NASDAQ:EOLS) Head to Head Comparison
Posted by Danessa Lincoln on Oct 14th, 2026 Evolus (NASDAQ:EOLS – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com5
- markets.businessinsider.com3
- biospace.com1
- globenewswire.com1
- kdhnews.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.